Each month our editorial team sifts through hundreds of papers and curates notable findings—for practitioners and informed readers who want to stay current with the evidence. Subscribe to the monthly Research Digest for expert analysis and concise summaries of key papers.
This article is a broad review of the new psychedelic industry. The authors look at how psychedelic drugs and clinics moved from decades-old research into a fast-growing business with hundreds of companies and big investment. They describe what companies are trying to sell, point out major scientific, legal, and ethical…
The Canadian Psychedelic Survey (CPS) surveyed 2,045 people in January 2022 about their use of psychedelic drugs in Canada. The survey found that psilocybin, MDMA, and LSD were the most used drugs. People most often used psychedelics for fun, self-exploration, general mental well-being, and personal growth. Large shares of respondents…
A 7-year follow-up survey of American psychiatrists found a clear shift toward more positive views of classic hallucinogens since 2016. Most psychiatrists who answered said they would plan to offer hallucinogen-assisted therapy if regulators approve it. The report also notes a 2023 finding that about 80.9% of psychiatrists agreed psychedelics…
Researchers looked at 94 Reddit posts and comments from the r/LSD forum that talked about gender and LSD. They found many people said LSD helped them explore or accept their gender, and some said it led them to change or plan to change their gender identity. The study used social…
While there is therapeutic potential for psychedelics in women's reproductive health issues, comprehensive research pertaining to women is lacking. While rigorous scientific inquiry into the safety, efficacy, and mechanisms of action of psychedelics in women's health is paramount, public health messaging should dispel myths and promote risk reduction strategies. Collaboration…
